First-in-Human Single Ascending Dose of SHR0302

NCT02423538 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: SHR0302
DRUG: SHR0302 placebo comparator

Sponsor

Jiangsu HengRui Medicine Co., Ltd.